Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study

BACKGROUND: Epirubicin, cisplatin, and 5-FU (ECF) is one of the most commonly used first-line chemotherapy regimens in metastatic gastric cancer. However, due to protracted infusion schedule, need for special infusion pumps, and catheter-related complications, the practical utility and acceptability...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, K. Govind, Chaudhuri, Tamojit, Lakshmaiah, K. C., Dasappa, Lokanatha, Jacob, Linu Abraham, Suresh Babu, M. C., Rudresha, A. H., Lokesh, K. N., Rajeev, L. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
ORIGINAL ARTICLE: GI Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498711/
https://www.ncbi.nlm.nih.gov/pubmed/31069184
http://dx.doi.org/10.4103/sajc.sajc_146_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498711/
https://www.ncbi.nlm.nih.gov/pubmed/31069184
http://dx.doi.org/10.4103/sajc.sajc_146_18

Ejemplares similares